coMra Therapy for Flu Prevention and Pediatric Care

Context

• Flu season in Northern Hemisphere
• Recent study (October 2017) questions effectiveness of H3N2 vaccine
• 33% effectiveness rate
• Concerns about long-term lowered immunity risk

Insights from Nurse Olga at Nikopol Neurorehabilitation Center for Children, Ukraine

Use of coMra Therapy

1. Treating severe neurological conditions
2. Managing flu and colds to enable other therapies

Effectiveness for Various Conditions

1. Enuresis (NREs)

• Two courses typically sufficient
• High parent satisfaction
• Significant reduction in symptoms

2. Pneumonia
3. Sinusitis

• Used during remission periods
• Effective as supportive therapy

4. Other conditions (e.g., tonsillitis, rhinitis, allergic sinusitis)

• Used as complementary treatment
• Pediatric application during remission periods

Overall Benefits

• Reduced frequency of illnesses
• Improved immunity regulation
• Facilitates rehabilitation processes

Comparison to Flu Vaccines

• coMra offers long-term improved immunity regulation
• Contrasts with potential long-term lowered immunity risk from flu shots

Applications

1. Fighting colds and flu
2. Staying above the wellness line
3. Foundation for child’s recovery from various health issues

Conclusion

• coMra therapy, especially with ComaPalm, offers an easy and effective way to maintain health
• Suggested as a preferable alternative to flu vaccines for immunity boost

This summary highlights the potential of coMra therapy in managing various pediatric conditions and boosting immunity, particularly as an alternative to traditional flu prevention methods.